Your browser doesn't support javascript.
loading
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study.
Morganti, Stefania; Marra, Antonio; Gandini, Sara; Ascione, Liliana; Ivanova, Mariia; Venetis, Konstantinos; Sajjadi, Elham; Zagami, Paola; Giugliano, Federica; Taurelli Salimbeni, Beatrice; Berton Giachetti, Pier Paolo Maria; Corti, Chiara; De Camilli, Elisa; Curigliano, Giuseppe; Fusco, Nicola; Criscitiello, Carmen.
Afiliação
  • Morganti S; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Marra A; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
  • Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Ascione L; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Ivanova M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Venetis K; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Sajjadi E; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Zagami P; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Giugliano F; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; INSERM U981 - Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Vi
  • Taurelli Salimbeni B; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
  • Berton Giachetti PPM; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Corti C; Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • De Camilli E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Curigliano G; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Criscitiello C; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: carmen.criscitiello@ieo.it.
Eur J Cancer ; 195: 113397, 2023 12.
Article em En | MEDLINE | ID: mdl-37890353
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Limite: Female / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neoplasias de Mama Triplo Negativas Limite: Female / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos